Introduction
Over the last years there has been an increasing consensus in considering that patient preferences should play an essential role in clinical decision making [1] . Indeed patient autonomy tend to be acknowledged as a value "per se". However the basic requirement is the provision of an adequate information on the yield of the health care intervention proposed. From the consumer side, a want for health translated into service consumption implies a demand for information about effectiveness, adequacy, risks and benefits and possible alternatives. The lack of knowledges about these aspects causes in consumer-patient an amount of anxiety about making a wrong decision which could have adverse health outcomes [2] . Without an adequate level of relevant information the patient tends to accept acritically every procedure proposed not only to maximize health benefits but also (in particular for diagnostic and screenings services) in the aim to "minimize regret". This last could be a rational choice under uncertainty due to a lack of information that could be relevant for decision making [3] .
While Wolf already showed that giving patients balanced information can change their intention in undergoing screening tests for prostate cancer [4] , we explore whether the same holds true when the target of the information is not the individual in a real patient-doctor encounter, but the general population at large exposed to a generic information, as it is usually the case for messages conveyed through public health interventions.
Methodology
On May 1998 a mailed questionnaire was sent to a representative sample (N=1000) of the Swiss general population aged over 20. Response rate was 87%. Participants were randomly allocated in two groups to receive "basic" (N=401) and "extended" (N=466) information about a screening test for pancreatic cancer and were asked to express their willingness to accept the screening procedure.
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This particular type of cancer was chosen because (i) it affects both 2 sexes, (ii) a blood test kit with poor sensibility and specificity is available (tumour marker CA 19.9) (iii) the annual incidence of the disease is relatively low and (iiii) the survival at 5 years is very poor.
The two scenarios ("basic" and "extended") provided respectively to the two groups of respondents, were: 
Results
Characteristics of respondents were similar in the two groups (see Table) . As expected (Figure) only 13,5% (N=63) of those receiving the "Extended" information stated their willingness to accept the test, as compared to 60% (N=237) of those exposed to the "Basic" one (P<0,001). 
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*see text
After adjusting for respondents characteristics through a logistic regression model allowing the 5 expression of the "information effect" in terms of odds ratio (OR), provision of additional information was related to a 91 % (95%CI; -87% to -94%) relative reduction of the likelihood of accepting the diagnostic test. Some personal characteristics appeared to be related to the acceptance of the test, regardless the amount of information provided. In particular, males were more likely to report their willingness to accept (OR 2,19; 95%CI: 1, 52-3, 16) as well as those with a passive (OR 3,57;
95%CI: 1, 74-7, 31) or collaborative doctor-patient relationship (OR 2,00; 95%CI: 1,09-3,68). Those of German language were also less willing to accept (OR 0,54; 95%CI: 0,36-0,80). Respondent's level education was not found related to willingness to be tested.
Comment
These results clearly show that the willingness to accept to undergo a test of questionable value is predicted by whether or not the public has been exposed to an "extended" level of information, although not personalised as it is usually the case during a medical consultation. We could say that information has a "protective" effect. According to these findings, about 80 % of individuals who would have agreed to undergo the test when exposed to "basic" information would change their mind after knowing more about the clinical implications of the test.
This last shows that content of information released is essential to over or under-estimate the real risk, as Viscusi has pointed out for smoking and lung cancer [5] .
Nevertheless the 60% (among those receiving "basic" information) agreeing to undergo a screening procedure for a rare cancer with very poor outcome is of concern. It shows how many consumers are bound to act acritically in front of every diagnostic procedure proposed, possibly due to their overoptimistic and "mythical" expectations.
This calls for the central responsibility both of institutions and doctors in providing the public and individuals with relevant evidence-based information. This could have two desirable effects, (i) make consumers/patients more aware about the real clinical effectiveness of the interventions proposed, and thus less exposed to the risk of accepting procedures of questionable value; (ii) to allow informed choices to find options more likely to fit with patient's values and preferences.
Facing the impressive increase of diagnostic procedures [6] , screening practices [7] , and the implementation of predictive medicine in the near future, it seems to be essential to develop a global strategy to enable a more active consumer role in clinical decision making, even among those who, because of their cultural attitudes, are more prone to rely completely on the subjective opinion of their own doctor. Provision of comprehensive research-based information can maximise patient freedom and autonomy in decision, allows a true "informed" consent, and can minimise the use of inappropriate or questionable diagnostic procedures and avoid waste of resources.
From a public health perspective these results highlight the need for community interventions aimed at empowering and encouraging the public to ask physicians the "right" questions before undergoing any suggested procedure [8] . Such a programme is currently ongoing in the Swiss region of Ticino, where, through a booklet targeted to all households [9] , the consumer-patient is 7 prompted to ask physician the following questions before undertaking any diagnostic test: There is already some empirical evidence that this approach can be successful. In 1984 a public information campaign in Canton Ticino (Switzerland) decreased hysterectomy rates by 26% [10] and a systematic review confirmed the effect of mass media campaigns on health service utilisation [11] .
In practical terms it could be feasible to develop, at least for the more frequently performed screening tests, a minimum set of evidence-based information the physician should deliver to each patient, allowing the time to reflect on before giving the informed consent.
Finally, these findings imply that the content of the currently produced leaflets and supports aimed at promoting community screenings should be carefully reviewed and critically assessed, to minimize the potential risk of misguiding the consumer-patient [12] .
